Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-04-04Clinical Trial Update: Genius Study Study to Compare Efficacy and Safety of Gefitinib/ Pemetrexed With Pemetrexed Alone as Maintenance Therapy in Patients With Stage IV EGFR Mutation Negative or T790M Single Mutation Who Respond to Pemetrexed/ Platinum as First-line Therapy [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial compares maintenance therapy with gefitinib plus pemetrexed versus pemetrexed alone in stage IV non-small c…
-
CLINICAL_TRIALS trial_result · 2014-04-03Clinical Trial Update: A Study of Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With Non Small Cell Lung Cancer [Phase 3]
Phase 3 study of a pemetrexed/cisplatin/gefitinib combination in Asian non-smoking patients with non-small cell lung cancer completed with r…
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Study of Participants With Advanced Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial update for participants with advanced non-small cell lung cancer; status completed with results posted in 2014.
-
CLINICAL_TRIALS withdrawal · 2014-03-31Clinical Trial Update: A Study to Assess the Safety and Preliminary Efficacy of PT-523 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
The study evaluating PT-523 in patients with advanced non-small cell lung cancer (Phase 1/2) has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial at the University of Chicago comparing cetuximab alone versus pemetrexed/cetuximab therapy for non-small cell lung cancer wa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: A Multi-Centered Trial Evaluating the Role of Vitamin D Metabolism in Non-Small Cell Lung Cancer
A multi-center clinical trial investigating Vitamin D metabolism in non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer [NA]
This National Cancer Institute-sponsored clinical trial update reports the completion of a study evaluating Erlotinib in patients with stage…
-
CLINICAL_TRIALS research · 2014-03-31Clinical Trial Update: NSCLC Burden of Illness Study
This GlaxoSmithKline-sponsored NSCLC burden of illness study has completed, providing an update on the clinical trial assessing the burden o…
-
CLINICAL_TRIALS research · 2014-03-31Clinical Trial Update: Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer [Phase 1]
Phase 1 trial evaluating vaccine therapy with or without sargramostim and with or without docetaxel in patients with metastatic lung cancer …
-
CLINICAL_TRIALS trial_result · 2014-03-27Clinical Trial Update: Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating radiation therapy with paclitaxel and carboplatin in stage III non-small cell lung cancer has completed with resu…
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC [Phase 3]
A Phase III trial evaluating RRM1 and ERCC1 directed customized chemotherapy for non-small cell lung cancer has completed and posted results…
-
CLINICAL_TRIALS trial_result · 2014-03-24Clinical Trial Update: Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
A completed Phase 1/2 study evaluating motesanib with or without carboplatin/paclitaxel or panitumumab in advanced non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: A Non-interventional Survey on the EGFR (Epidermal Growth Factor Receptor) Mutation Status in Completely Resected Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Adenocarcinoma Histology
AstraZeneca-conducted, non-interventional study completed, surveying EGFR mutation status in Chinese patients with completely resected non-s…
-
CLINICAL_TRIALS trial_result · 2014-03-17Clinical Trial Update: Celecoxib and Radiation Therapy in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Completed phase 1/2 trial evaluating the combination of celecoxib with radiation therapy in locally advanced non-small cell lung cancer; res…
-
CLINICAL_TRIALS trial_result · 2014-03-17Clinical Trial Update: Multimodal Hypoxia Imaging and Intensity Modulated Radiotherapy for Inoperable Non-small-cell Lung Cancer [NA]
This clinical trial update notes the termination of a study evaluating multimodal hypoxia imaging combined with intensity-modulated radiothe…
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: A Dose Ascending Study of Gemcitabine Elaidate (CO-101) in Combination With Cisplatin [Phase 1]
Phase 1 dose-escalation study of gemcitabine elaidate (CO-101) with cisplatin for solid tumors, including non-small cell lung cancer, has be…
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer [Phase 2]
Phase II trial assessing carboplatin plus gemcitabine in patients with Stage IIIB non-small cell lung cancer and Stage IV non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2014-03-06Clinical Trial Update: Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating palifermin for reducing dysphagia in locally advanced non-small cell lung cancer has completed, with results posted…
-
CLINICAL_TRIALS trial_result · 2014-03-06Clinical Trial Update: Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating bevacizumab with paclitaxel and carboplatin plus chest radiation for locally advanced non-small cell lung cancer; t…
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer [Phase 1]
This is a completed Phase 1 study evaluating fondaparinux (Arixtra) in combination with chemotherapy for patients with advanced non-small ce…
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC) [Phase 2]
Phase 2 trial evaluating cetuximab with conformal thoracic radiotherapy in patients with inoperable or unresectable locally advanced non-sma…
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
A Phase 3 clinical trial evaluating Tarceva (erlotinib) in patients with advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS withdrawal · 2014-03-04Clinical Trial Update: Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light [Phase 2]
A Phase 2 clinical trial evaluating a sunscreen to prevent porfimer sodium–induced phototoxicity to visible light has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-03-03Clinical Trial Update: Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating a biweekly schedule of docetaxel and cisplatin in unresectable non-small cell lung cancer. The study is completed a…
-
CLINICAL_TRIALS research · 2014-03-03Clinical Trial Update: Identification by Microarrays of the Risks of Metastatic Relapse, Toxicity and Resistance to Adjuvant Chemotherapy in Completely Resected Non-small Cell Lung Cancer
This clinical trial update describes a study using microarrays to identify risks of metastatic relapse, toxicity, and resistance to adjuvant…